Paris has always had a heart-istic side, and it was pumping with excitement, especially last week. Nipro Group’s vascular team from Japan, Europe, and India landed in Paris for EuroPCR 2023 – one of the biggest stages for the vascular sector.
EuroPCR is one of the world’s leading conferences in interventional cardiovascular medicine that focuses on training and education.
- 11,500+ visitors
- 97 industry partners
- 400 educational sessions
- 16 live cases from 5 live centers
- 96 sessions live-streamed
- Many more highlights
These distinctions made it the perfect venue to meet our existing distributors, potential customers, and valued partners. It allowed us to discuss the latest innovations in intracoronary imaging and what is to come this year.
What made us stand out!
Our products
HF-OCT and Makoto IVUS+NIRS - the star products that everyone was talking about and wanted to see at our booth. Beside the intracoronary imaging systems, our visitors were excited about our interventional PCI and diagnostic product line.
Our symposia
Nipro Group organized two fascinating symposia – both featuring HF-OCT. In packed rooms, the symposia captivated the audience with how the advanced HF-OCT technology overcomes the limitations of current intracoronary imaging in PCI procedures. It was a day of learning and insightful discussions.
Key notes from the symposia
- HF-OCT has an increased ability to access challenging lesions without having to pre-dilate.
- HC-OCT can capture the entire area of interest in 1 pullback (100mm).
- HF-OCT achieves contrast reduction with catheter size and pullback speed (100m/1 second).
- HF-OCT has no left main restriction due to increased scan range.
Our teamwork
EuroPCR 2023 was a great stage to display Nipro Group’s diversity in terms of partners and vascular teams from three regions – Japan, Europe, and India. The team worked like clockwork, and as the popular saying goes, "Teamwork makes the dream work."
“The highlight would be networking with our valuable customers, distributors, and friends. What was truly amazing the “ONE Nipro” teamwork! We work effortlessly together with Nipro Medical India, Nipro Japan, Infraredx, Gentuity."
Markus Stoehr, Marketing Manager Vascular
Future developments
Nipro’s next big international vascular conference will be Transcatheter Cardiovascular Therapeutics (TCT) in October (San Francisco, USA). As we prepare for it, stay tuned as we keep up the pace with HF-OCT and NIRS+IVUS.
1 beautiful city, 4 electrifying days, 2 insightful symposia, 23 enthusiastic Nipro attendees - alone, we can do so little; together, we can do so much.
Vascular products
Vascular
Nipro provides invaluable tools for interventional cardiologists to have a concise understanding of the best treatment strategies for the patient.
